Chemokines in rheumatic diseases

Curr Drug Targets. 2006 Jan;7(1):91-102. doi: 10.2174/138945006775270231.

Abstract

Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the inflamed synovium. In this review, authors discuss the role of the most relevant chemokines and chemokine receptors involved in chronic inflammatory rheumatic diseases. Rheumatoid arthritis was chosen as a prototype to discuss these issues, as the majority of studies on the role of chemokines in inflammatory diseases were carried out in arthritis. However, other rheumatic diseases including systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, mixed connective tissue disease, polymyositis/dermatomyositis, antiphospholipid syndrome and systemic vasculitides are also discussed in this context. Apart from discussing the pathogenic role of chemokines and their receptors, authors also review the regulation of chemokine production by other inflammatory mediators, as well as the important relevance of chemokines for antirheumatic therapies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Antirheumatic Agents / pharmacology*
  • Arthritis, Psoriatic / drug therapy
  • Arthritis, Psoriatic / physiopathology
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / physiopathology
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / physiopathology
  • Chemokines / antagonists & inhibitors
  • Chemokines / biosynthesis
  • Chemokines / physiology*
  • Humans
  • Rheumatic Diseases / physiopathology*
  • Spondylarthropathies / drug therapy
  • Spondylarthropathies / physiopathology
  • Synovitis / metabolism

Substances

  • Antirheumatic Agents
  • Chemokines